[1]
M. Tığlıoğlu, “Analysis of factors predicting the efficacy of Imatinib in patients with Chronic Myeloid Leukemia: A retrospective analysis”, Med Sci Discov, vol. 9, no. 9, pp. 532–536, Sep. 2022.